HORIZON THERAPEUTICS PLC - COMMON STOCK-FO (HZNP)

Historical Holders from Q1 2019 to Q3 2025

Symbol
HZNP
Type / Class
Equity / COMMON STOCK-FO
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
1
Holdings value
$116
Number of holders
1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of HORIZON THERAPEUTICS PLC - COMMON STOCK-FO (HZNP)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 1 $116 $116.00 1
2025 Q2 1 $116 $116.00 1
2025 Q1 1 $116 $116.00 1
2024 Q4 1 $116 $116.00 1
2024 Q3 1 $116 -$3,834 $116.00 1
2024 Q2 36 $3,950 +$3,834 $112.77 2
2024 Q1 1 $116 -$49,261 $116.00 1
2023 Q4 426 $49,377 -$24,699,897,879 $115.71 6
2023 Q3 214,357,019 $24,798,814,679 +$1,242,090,174 $115.69 476
2023 Q2 205,310,351 $21,118,883,631 -$146,065,915 $102.85 508
2023 Q1 205,828,158 $22,460,111,954 -$338,195,908 $109.14 543
2022 Q4 209,062,727 $23,789,457,142 +$339,626,925 $113.80 599
2022 Q3 210,348,573 $13,021,872,777 -$167,259,810 $61.89 507
2022 Q2 206,840,549 $16,504,468,491 -$99,220,163 $79.76 598
2022 Q1 207,298,360 $21,830,521,069 +$404,550,727 $105.21 611
2021 Q4 203,574,279 $21,929,761,839 -$33,409,262 $107.76 600
2021 Q3 202,236,961 $22,147,713,319 +$95,789,164 $109.54 565
2021 Q2 201,445,638 $18,856,722,038 +$313,258,553 $93.64 524
2021 Q1 199,805,216 $18,384,399,146 -$30,110,453 $92.04 505
2020 Q4 202,906,893 $14,848,395,953 +$122,934,582 $73.15 484
2020 Q3 200,083,220 $15,547,804,340 +$939,522,566 $77.68 426
2020 Q2 188,074,122 $10,459,526,480 +$878,007,870 $55.58 347
2020 Q1 173,351,630 $5,137,539,633 +$89,646,867 $29.62 284
2019 Q4 170,996,449 $6,187,486,262 +$69,001,924 $36.20 275
2019 Q3 167,195,876 $4,551,631,936 +$318,559,872 $27.23 252
2019 Q2 155,837,654 $3,748,757,857 +$3,689,401,958 $24.06 250
2019 Q1 2,379,706 $62,898,000 +$62,897,992 $26.43 11